KKM-191-D by Genuone Science for Type 2 Diabetes: Likelihood of Approval

KKM-191-D is under clinical development by Genuone Science and is currently in the Phase I in clinical pathway.

Aug 10, 2023 - 20:00

KKM-191-D is under clinical development by Genuone Science and is currently in the Phase I in clinical pathway.

Read the original article

Tags:

Previous Article

JY-302 by Jin Yang Pharmaceutical for Type 2 Diabetes: Likelihood of Approval

CD70 CAR-T by UTC Therapeutics for Marginal Zone B-cell Lymphoma: Likelihood of ...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

(Curcumin + doxorubicin) by Immix BioPharma for Metasta...

Dec 24, 2023

STAT+: In major test for eGenesis, gene-edited pig kidneys kept monkeys alive for more than two years

STAT+: In major test for eGenesis, gene-edited pig kidn...

Oct 12, 2023

US FDA expands approval for Merck’s PREVYMIS (letermovir)

US FDA expands approval for Merck’s PREVYMIS (letermovir)

Jun 7, 2023